Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 45: 778-782, 1978;
8750-7587/78 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hensley, M. J.
Right arrow Articles by Ingram, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hensley, M. J.
Right arrow Articles by Ingram, R. H., Jr

Journal of Applied Physiology, Vol 45, Issue 5 778-782, Copyright © 1978 by American Physiological Society


ARTICLES

Distribution of bronchodilatation in normal subjects: beta agonist versus atropine

M. J. Hensley, C. F. O'Cain, E. R. McFadden Jr and R. H. Ingram Jr

Bronchodilatation was produced in normal subjects by the inhalation of a parasympatholytic agent (atropine) and the response was compared to that occurring after the inhalation of a beta-adrenergic agent (isoetharine). Doses were chosen that resulted in equivalent increases in specific airway conductance (78 +/- 9% for atropine; 88 +/- 21% for isoetharine). Anatomic dead space and volume at the onset of the terminal nitrogen rise (closing volume) were measured before and after each agent. Although there was no difference in the degree of overall bronchodilatation after the two drugs, anatomical dead space increased significantly more after atropine than isoetharine (+17% vs. +6%, P less than 0.01), and closing volume increased significantly after isoetharine (P less than 0.005) but did not change with atropine. We interpret these differences to indicate a greater effect of cholinergic antagonists on the more central airways and a greater effect of beta-adrenergic stimulants on peripheral airways.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Beydon, F. Amsallem, M. Bellet, M. Boule, M. Chaussain, A. Denjean, R. Matran, B. Wuyam, C. Alberti, and C. Gaultier
Pre/Postbronchodilator Interrupter Resistance Values in Healthy Young Children
Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1388 - 1394.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
J. Freeman and L. I. Landau
The Effects of Ipratropium Bromide and Fenoterol Nebulizer Solutions in Children with Asthma
Clinical Pediatrics, December 1, 1989; 28(12): 556 - 560.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online